Spravato, the brand name for esketamine, has a newly approved indication for treatment-resistant depression. tadamichi/Getty Images/iStockphoto tadamichi/Getty Images/iStockphoto The U.S. Food and Drug Administration has
Read moreVerify All Oil Trade Documents